Are you Dr. Rollins?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 46 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Dana-Farber Cancer Inst
44 Binney Street
Boston, MA 02115Phone+1 617-632-3896- Is this information wrong?
Summary
- Dr. Barrett Rollins, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Dana-Farber Cancer Institute and is a Linde Family Professor of Medicine at Dana-Farber Cancer Institute.
Education & Training
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1980 - 1983
Case Western Reserve University School of MedicineClass of 1980
Certifications & Licensure
MA State Medical License 1983 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1996
Publications & Presentations
PubMed
- 10 citationsMatchMiner: an open-source platform for cancer precision medicine.Harry Klein, Tali Mazor, Ethan Siegel, Pavel Trukhanov, Andrea Ovalle, Catherine Del Vecchio Fitz, Zachary Zwiesler, Priti Kumari, Bernd Van Der Veen, Eric Marriott, J...> ;NPJ Precision Oncology. 2022 Oct 6
- 17 citationsHistiocytosis.Jean-François Emile, Fleur Cohen-Aubart, Matthew Collin, Sylvie Fraitag, Ahmed Idbaih, Omar Abdel-Wahab, Barrett J Rollins, Jean Donadieu, Julien Haroche> ;Lancet. 2021 Jul 10
- 24 citationsGenomic Characterization of de novo Metastatic Breast CancerAna C. Garrido-Castro, Liam F. Spurr, Melissa E. Hughes, Yvonne Y. Li, Andrew D. Cherniack, Priti Kumari, Maxwell R. Lloyd, Brittany L. Bychkovsky, Romualdo Barroso-So...> ;Clinical Cancer Research. 2021 Feb 15
- Join now to see all
Press Mentions
Computer Platform Helps Match Patients with Cancer to Trials of Targeted TherapyOctober 12th, 2022- The Evolution of Precision Medicine -News ForestAugust 26th, 2022
Lilly Announces Extension of Cancer Research Collaboration with Dana-Farber Cancer InstituteJuly 30th, 2018- Join now to see all
Grant Support
- Cutaneous Immunity And VacciniaNational Institute Of Allergy And Infectious Diseases2008
- Fortieth Annual Meeting Of The Society For Leukocyte BiologyNational Institute Of Allergy And Infectious Diseases2007
- Chemokines And Graft-Versus-Host DiseaseNational Heart, Lung, And Blood Institute2007
- Molecular Pathobiology Of Langerhans Cell HistiocytosisNational Institute Of Allergy And Infectious Diseases2003–2007
- Functional Analysis Of A PDGF Inducible CytokineNational Cancer Institute2001–2005
- 2004 Gordon Research Conference On Chemotactic CytokinesNational Institute Of Allergy And Infectious Diseases2004
- Human Subjects Research Protections Outreach ProjectNational Center For Research Resources2003
- Molecular Pathobiology Of Langerhans Cell HistiocytosisNational Institute Of Allergy And Infectious Diseases2002
- Cyclin C Associated Proteins In Lung CancerNational Cancer Institute1997–2001
- Functional Analysis Of A Pdgf-Inducible CytokineNational Cancer Institute1991–2000
- Functional Analysis Of A Pdgf-Inducible CytokineNational Cancer Institute1989–1990
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
